Latest debt-to-equity ratio
Cullinan Therapeutics Debt-to-equity ratio
Direct answer
Cullinan Therapeutics's debt-to-equity ratio is 0.64%.
The verified market snapshot reports 0.64%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 23, 2026.
Get free Cullinan Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 0.64%
Explore related company data
View Cullinan Therapeutics's market capitalizationView Cullinan Therapeutics's price-to-book ratioView Cullinan Therapeutics's return on equityView Cullinan Therapeutics's 52-week price rangeView Cullinan Therapeutics's profit marginView all Cullinan Therapeutics key metricsReturn to Cullinan Therapeutics profile